Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma
Clinical trial NCT07225621 · RECRUITING
Trial details
- NCT number
- NCT07225621
- Sponsor
- Alpheus Medical, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-28
- Primary completion
- 2027-12-01
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.